Header Logo

Tashanna Myers

Concepts (85)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
8
2023
120
1.140
Why?
Endometrial Neoplasms
2
2013
53
0.520
Why?
Pelvic Organ Prolapse
1
2013
22
0.450
Why?
Minimally Invasive Surgical Procedures
1
2013
79
0.450
Why?
Carcinoma
1
2013
110
0.430
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2023
297
0.410
Why?
Thiones
1
2008
4
0.340
Why?
Chromans
1
2008
14
0.330
Why?
B7-H1 Antigen
3
2023
45
0.330
Why?
Angiogenesis Inhibitors
1
2008
69
0.320
Why?
Neovascularization, Pathologic
1
2008
123
0.310
Why?
Maytansine
1
2023
2
0.240
Why?
Quality of Life
1
2023
852
0.150
Why?
Chemotherapy, Adjuvant
3
2009
82
0.120
Why?
Sterilization, Tubal
1
2012
9
0.110
Why?
Uterine Cervical Dysplasia
1
2012
24
0.110
Why?
Vaginal Smears
1
2012
51
0.110
Why?
Female
10
2023
27507
0.100
Why?
Carcinoma, Squamous Cell
1
2012
149
0.100
Why?
Uterine Cervical Neoplasms
1
2012
140
0.100
Why?
Double-Blind Method
2
2023
559
0.100
Why?
Antibodies, Monoclonal, Humanized
2
2023
185
0.100
Why?
Early Detection of Cancer
1
2012
237
0.090
Why?
Aged
6
2021
11572
0.090
Why?
Paclitaxel
3
2021
65
0.090
Why?
Humans
11
2023
52901
0.090
Why?
Adenocarcinoma
1
2012
334
0.090
Why?
Thymidine Phosphorylase
1
2008
2
0.080
Why?
Aged, 80 and over
6
2021
4467
0.080
Why?
Neoplasm Staging
3
2021
412
0.080
Why?
Xenograft Model Antitumor Assays
1
2008
160
0.080
Why?
Endothelial Cells
1
2008
161
0.070
Why?
Dose-Response Relationship, Drug
1
2008
732
0.070
Why?
Carboplatin
2
2021
19
0.070
Why?
Gene Expression Regulation, Neoplastic
1
2008
455
0.070
Why?
Cell Line, Tumor
1
2008
1251
0.060
Why?
Cell Proliferation
1
2008
891
0.060
Why?
Platinum Compounds
1
2023
1
0.060
Why?
Folate Receptor 1
1
2023
2
0.060
Why?
Cell Line
1
2008
1936
0.060
Why?
Immunoconjugates
1
2023
72
0.060
Why?
Abdominal Pain
1
2023
87
0.060
Why?
Patient Reported Outcome Measures
1
2023
92
0.050
Why?
Drug Resistance, Neoplasm
1
2023
162
0.050
Why?
Cytoreduction Surgical Procedures
1
2021
6
0.050
Why?
Immunotherapy
1
2023
202
0.050
Why?
Bevacizumab
1
2021
47
0.050
Why?
Neoadjuvant Therapy
1
2021
66
0.050
Why?
Genomics
1
2023
285
0.050
Why?
Biomarkers, Tumor
1
2023
400
0.050
Why?
Middle Aged
5
2021
14052
0.050
Why?
Organoplatinum Compounds
2
2008
15
0.040
Why?
Adult
4
2021
13802
0.040
Why?
Adolescent
2
2021
5405
0.030
Why?
Mutation
1
2023
2209
0.030
Why?
Mice
1
2008
9540
0.030
Why?
Retrospective Studies
3
2009
5142
0.030
Why?
Oklahoma
1
2012
6
0.030
Why?
Colposcopy
1
2012
21
0.030
Why?
Young Adult
1
2021
3820
0.030
Why?
Animals
1
2008
18206
0.020
Why?
Karnofsky Performance Status
1
2009
11
0.020
Why?
Creatinine
1
2009
117
0.020
Why?
Radiotherapy, Adjuvant
1
2008
52
0.020
Why?
Logistic Models
1
2012
1203
0.020
Why?
Drug Administration Schedule
1
2009
250
0.020
Why?
Disease-Free Survival
1
2008
183
0.020
Why?
Cyclophosphamide
1
2008
57
0.020
Why?
Neoplasm Metastasis
1
2008
185
0.020
Why?
Gynecologic Surgical Procedures
1
2008
40
0.020
Why?
Infusions, Parenteral
1
2007
17
0.020
Why?
Cisplatin
1
2007
59
0.020
Why?
Arrhythmias, Cardiac
1
2008
99
0.020
Why?
Catheters, Indwelling
1
2007
61
0.020
Why?
Combined Modality Therapy
1
2007
295
0.020
Why?
Survival Rate
1
2008
665
0.020
Why?
Weight Loss
1
2009
277
0.020
Why?
Case-Control Studies
1
2008
965
0.020
Why?
Cross-Sectional Studies
1
2012
2303
0.020
Why?
Patient Compliance
1
2007
336
0.020
Why?
Comorbidity
1
2008
1013
0.020
Why?
Surveys and Questionnaires
1
2012
2366
0.020
Why?
Risk Factors
1
2012
4473
0.010
Why?
Cohort Studies
1
2008
2189
0.010
Why?
Treatment Outcome
1
2008
4223
0.010
Why?
Myers's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (85)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_